Hao Lu, Ph.D., joined Nurix Therapeutics in July 2021 and has served as Vice President of Discovery Pharmacology since July 2024. With over 15 years of experience in drug discovery for small molecules and biologics, Dr. Lu has played a key role in advancing therapeutic candidates across a range of areas, including oncology, immune-oncology, immunology, and infectious diseases. Before joining Nurix, he held position at EMD Serono and Bristol-Myers Squibb. Dr. Lu earned his B.S. in Chemistry from The Chinese University of Hong Kong, graduating with first-class honors, and his Ph.D. in Biochemistry and Chemical Biology from Stony Brook University.
'